Discover Novel Therapeutic Strategies for Peritoneal Metastases from Gastric Adenocarcinoma
Abstract
Through this grant we have not only published 4 high-impact papers, we identified cancer stem cells role in aggressive behavior of peritoneal carcinomatosis. We have developed new cell lines and animal models. We identified which oncogene (Yap1) drives peritoneal carcinomatosis and we could reduce the incidence of peritoneal metastases. We have extensively characterized PDX models and cell lines (these will be useful resources to the oncology community). We have accomplished single cell sequencing in 20 patients with unique results to be published in Nature Medicine. Discovered crosstalk between TRIM28 and Yap1 (potentially both can be exploited in the clinic). We have defined proteomics of peritoneal cells at the mass spect level (never been reported for gastric cancer) and defined mRNAs as well a unique long-non-coding RNA (CCAT2) that regulated chromosomal instability. We are now poised to take our discoveries to the next level.
Document Details
- Document Type
- Technical Report
- Publication Date
- Dec 01, 2020
- Accession Number
- AD1130917
Entities
People
- George A. Calin
Organizations
- The University of Texas MD Anderson Cancer Center